Touchstone International Medical Science Co Ltd (688013) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Touchstone International Medical Science Co Ltd (688013) has a cash flow conversion efficiency ratio of 0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥27.05 Million ≈ $3.96 Million USD) by net assets (CN¥599.62 Million ≈ $87.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Touchstone International Medical Science to measure how many days the company can operate on defensive assets alone.
Touchstone International Medical Science Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Touchstone International Medical Science Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Touchstone International Medical Science Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Touchstone International Medical Science Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RMR Group Inc
NASDAQ:RMR
|
0.121x |
|
Yulie Sekurindo Tbk
JK:YULE
|
-0.032x |
|
FibraHotel
MX:FIHO12
|
0.027x |
|
Gateway Distriparks Limited
NSE:GATEWAY
|
0.079x |
|
Sky Harbour Group Corporation
NYSE:SKYH
|
-0.024x |
|
SMS Electric Co Ltd Zhengzhou
SHE:002857
|
-0.037x |
|
Putnam Premier Income Trust
NYSE:PPT
|
N/A |
|
Mirbud SA
WAR:MRB
|
0.000x |
Annual Cash Flow Conversion Efficiency for Touchstone International Medical Science Co Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of Touchstone International Medical Science Co Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Touchstone International Medical Science.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥581.43 Million ≈ $85.08 Million |
CN¥53.41 Million ≈ $7.82 Million |
0.092x | -36.71% |
| 2023-12-31 | CN¥571.52 Million ≈ $83.63 Million |
CN¥82.95 Million ≈ $12.14 Million |
0.145x | +46.40% |
| 2022-12-31 | CN¥508.41 Million ≈ $74.40 Million |
CN¥50.40 Million ≈ $7.38 Million |
0.099x | -16.74% |
| 2021-12-31 | CN¥512.13 Million ≈ $74.94 Million |
CN¥60.98 Million ≈ $8.92 Million |
0.119x | +31.82% |
| 2020-12-31 | CN¥465.89 Million ≈ $68.17 Million |
CN¥42.08 Million ≈ $6.16 Million |
0.090x | -72.20% |
| 2019-12-31 | CN¥107.18 Million ≈ $15.68 Million |
CN¥34.82 Million ≈ $5.10 Million |
0.325x | -21.80% |
| 2018-12-31 | CN¥82.90 Million ≈ $12.13 Million |
CN¥34.44 Million ≈ $5.04 Million |
0.415x | +320.71% |
| 2017-12-31 | CN¥79.84 Million ≈ $11.68 Million |
CN¥7.88 Million ≈ $1.15 Million |
0.099x | -- |
About Touchstone International Medical Science Co Ltd
Touchstone International Medical Science Co., Ltd. researches and develops, manufactures, and sells medical devices in China, the United States, Europe, Japan, Russia, Brazil, South Korea, Canada, Australia, and internationally. It provides laparoscopic, tube-type, intraluminal, endoscopic linear cutters and reloads, linear cutters and reloads, auto purse string clamps, and linear staplers and re… Read more